BACKGROUND/ OBJECTIVES:Vitamin D mediates immunomodulatory functions, and its deficiency has been associated with an increased prevalence of immunological diseases. The supplementation of vitamin D might be therapeutically beneficial, for example, in lupus erythematosus patients. However, its affect on established recall immune responses is undefined. SUBJECTS/ METHODS: In all, 32 individuals were randomized in a placebo controlled, double-blind setting, and received vitamin D (daily 2000 IU) for 10 weeks followed by tetanus toxoid (TT) booster immunization. RESULTS: During vitamin D supplementation the median 25-hydroxyvitamin D serum concentration increased to 80.3 nM, which as expected decreased in the placebo group to 29.1 nM during the ultraviolet-deprived winter months. The TT-specific immunoglobulin G (IgG) boost efficiency was marginal higher in the vitamin D group (P = 0.04). The increase of the 25-hydroxyvitamin D levels correlated with the increase of TT-IgG serum concentrations. The induction of specific serum IgA and specific antibody secreting cells was comparable between both groups. Accordingly, the TT-specific and polyclonally triggered T-cell cytokine profiles were stable as well. CONCLUSIONS:Vitamin D supplementation was successful and booster immunization induced efficiently specific antibodies titers.
RCT Entities:
BACKGROUND/ OBJECTIVES:Vitamin D mediates immunomodulatory functions, and its deficiency has been associated with an increased prevalence of immunological diseases. The supplementation of vitamin D might be therapeutically beneficial, for example, in lupus erythematosuspatients. However, its affect on established recall immune responses is undefined. SUBJECTS/ METHODS: In all, 32 individuals were randomized in a placebo controlled, double-blind setting, and received vitamin D (daily 2000 IU) for 10 weeks followed by tetanus toxoid (TT) booster immunization. RESULTS: During vitamin D supplementation the median 25-hydroxyvitamin D serum concentration increased to 80.3 nM, which as expected decreased in the placebo group to 29.1 nM during the ultraviolet-deprived winter months. The TT-specific immunoglobulin G (IgG) boost efficiency was marginal higher in the vitamin D group (P = 0.04). The increase of the 25-hydroxyvitamin D levels correlated with the increase of TT-IgG serum concentrations. The induction of specific serum IgA and specific antibody secreting cells was comparable between both groups. Accordingly, the TT-specific and polyclonally triggered T-cell cytokine profiles were stable as well. CONCLUSIONS:Vitamin D supplementation was successful and booster immunization induced efficiently specific antibodies titers.
Authors: Richard K Zimmerman; Chyongchiou Jeng Lin; Jonathan M Raviotta; Mary Patricia Nowalk Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452
Authors: E Peelen; G Rijkers; A Meerveld-Eggink; S Meijvis; M Vogt; J W Cohen Tervaert; R Hupperts; J Damoiseaux Journal: Eur J Clin Microbiol Infect Dis Date: 2012-08-09 Impact factor: 3.267
Authors: Ian Handel; Kathryn A Watt; Jill G Pilkington; Josephine M Pemberton; Alastair Macrae; Philip Scott; Tom N McNeilly; Jacqueline L Berry; Dylan N Clements; Daniel H Nussey; Richard J Mellanby Journal: Sci Rep Date: 2016-01-13 Impact factor: 4.379
Authors: Edwin Hoe; Jordan Nathanielsz; Zheng Quan Toh; Leena Spry; Rachel Marimla; Anne Balloch; Kim Mulholland; Paul V Licciardi Journal: Nutrients Date: 2016-12-12 Impact factor: 5.717